biontech se


Close Chg Chg %
86.17 0.64 0.74%

Closed Market


+0.64 (0.74%)

Volume: 1.58M

Last Updated:

Apr 19, 2024, 4:00 PM EDT


Pfizer COVID-19 vaccine less effective in ages 5-11: study

Two doses of the Pfizer Inc. and BioNTech SE COVID-19 vaccine was protective against severe disease in children aged 5 to 11 during the recent omicron variant surge, but quickly lost most of its ability to prevent infection in the age group, according to a study by New York State researchers.